Finding the best prices at pharmacies near you...


Melanoma

Melanoma

Melanoma is a form of skin cancer that attacks the skin's pigment, which is called melanin. It is most commonly found in areas of the skin regularly exposed to the sun, but may also develop in the eyes, internal organs, and intestines. 

Symptoms of melanoma include the appearance of a new, abnormal-looking mole, or a change in the shape and color of an existing mole. Signs to watch for in moles are irregular shapes, multiple colors, or an uneven distribution of color. 

It is usually caused by exposure to ultraviolet radiation, for example, tanning beds, lamps, and sunlight. Other risk factors include: being female and over 40, paler skin, and family history of melanoma. 

Melanoma is usually diagnosed with a biopsy and treatment includes surgical options, such as removal of affected areas. Medication in the form of chemotherapy and radiation therapy may also be part of melanoma treatment. 

Drug classes often used to treat melanoma include protein kinase inhibitors, interferon alphas, antineoplastic monoclonal antibodies, and PD inhibitors.


Drugs Used To Treat Melanoma:

Antineoplastic Monoclonal Antibodies
Commonly used to treat Melanoma, Hodgkin's Disease, head and neck cancer.

Drugs Related to Melanoma:

Antineoplastic Monoclonal Antibodies
Commonly used to treat Melanoma, Hodgkin's Disease, head and neck cancer.

Blog Posts Related to Melanoma:

Get Ready for Summer! FDA highlights importance of sunscreen

Americans have been urged to take precautions to protect against ultraviolet (UV) radiation and skin cancer during the hotter months of the year. In a statement issued by the US Food and Drug Administration (FDA), FDA Commissioner Scott Gottlieb, MD, highlighted the dangers and prevalence of skin...

Read More

Benefits of Keytruda 'outweigh risks for approved uses'

The US Food and Drug Administration (FDA) has issued a statement clarifying its position on Keytruda (pembrolizumab) after scientists monitoring studies of the drug found an excess of deaths among patients given the drug in combination with certain other medicines.  Currently, Keytruda is...

Read More

Cancer medication based on biomarker "an important first"

The US Food & Drug Administration's (FDA) decision to approve a medication to treat patients whose cancer has a specific genetic feature, or biomarker, has been hailed as an "important first" in the fight against the disease. Keytruda (pembrolizumab) is a monoclonal antibody already in use to...

Read More